Return to homepagePandemic Pact

The added value of IS-pro technique at the accident and emergency department for identifying a bacterial infection and predicting the severity of SARS-CoV-2 in in patients with suspected COVID-19

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2020
    2021

  • Funder

    NWO Netherlands

  • Principal Investigator

    Dr. Prabath Nanayakkara

  • Research Location

    Netherlands

  • Lead Research Institution

    Amsterdam UMC

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

With this retrospective study we want to reduce the unnecessary use of antibiotics in the future and improve the prognosis of COVID-19 patients. With this we will ensure improved patient outcomes, reduced antibiotic resistance among the population and with this reduce care costs too.